COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101544 · Cited by 2,397

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Haas, E. J., Angulo, F. J., McLaughlin, J. M., Anis, E., Singer, S. R., Khan, F., Brooks, N., Smaja, M., Mircus, G., Pan, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00947-8 · Cited by 1,564

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H. L., Yoon, S. K., Meece, J., Olsho, L. E. W., Caban-Martinez, A. J., Fowlkes, A., Lutrick, K., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7013e3 · Cited by 707

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Tenforde, M. W., Olson, S. M., Self, W. H., Talbot, H. K., Lindsell, C. J., Steingrub, J. S., Shapiro, N. I., Ginde, A. A., Douin, D. J., Prekker, M. E., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7018e1 · Cited by 286

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

Wallace, M. M., Woodworth, K. R., Gargano, J. W., Scobie, H. M., Blain, A. E., Moulia, D., Chamberland, M. E., Reisman, N., Hadler, S. C., MacNeil, J. R., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7020e1 · Cited by 141

Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2

Paden, C. R., Tao, Y., Queen, K. J., Zhang, J., Li, Y., Uehara, A., & Tong, S. (2020) · Emerging infectious diseases · doi:10.3201/eid2610.201800 · Cited by 135

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening

Tande, A. J., Pollock, B. D., Shah, N. D., Farrugia, G., Virk, A., Swift, M., Breeher, L., Binnicker, M., & Berbari, E. F. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab229 · Cited by 120

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel

Swift, M. D., Breeher, L. E., Tande, A. J., Tommaso, C. P., Hainy, C. M., Chu, H., Murad, M. H., Berbari, E. F., & Virk, A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab361 · Cited by 98

Clinical Characterization and Outcomes of Patients with Hypercreatinemia Affected by COVID-19

Elkhalifa, A. M. E., Shah, N. N., Khan, Z., Ali, S. I., Nabi, S. U., Bashir, S. M., Mir, M. S., Bazie, E. A., Elderdery, A. Y., Alanazi, A., et al. (2023) · Healthcare · doi:10.3390/healthcare11070944 · Cited by 1

Analyzing COVID-19 Vaccine Adverse Reactions Using Machine Learning Techniques

Albayati, M. B., & Altamimi, A. M. (2023) · Karbala International Journal of Modern Science · doi:10.33640/2405-609x.3271 · Cited by 1

Efektivitas Vaksinasi terhadap Tingkat Keparahan Covid-19

Fauziah, D. A., & Sari, D. N. (2023) · Jurnal Epidemiologi Kesehatan Indonesia · doi:10.7454/epidkes.v7i1.6374 · Cited by 1

Assessment of pharmacy students’ awareness and knowledge of the COVID-19 pandemic and vaccines in Jordan: A cross-sectional study at private universities

Salama, A. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e107592 · Cited by 1

Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period

Sternberg, M., Johnson, A. G., King, J., Ali, A. R., Linde, L., Awofeso, A. O., Baker, J. S., Bayoumi, N. S., Broadway, S. E., Busen, K., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291678 · Cited by 2

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

Panchawagh, S., Ravichandran, N., Barman, B., Nune, A., Javaid, M., Gracia‐Ramos, A. E., Day, J. A., Joshi, M., Kuwana, M., Saha, S., et al. (2023) · Rheumatology International · doi:10.1007/s00296-023-05496-y · Cited by 1

Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study

Hoff, L. S., Ravichandran, N., Sen, P., Day, J. A., Joshi, M. M., Nune, A., Nikiphorou, E., Saha, S., Tan, A. L., Shinjo, S. K., et al. (2024) · Lara D. Veeken · doi:10.1093/rheumatology/keae128 · Cited by 1

Breakthrough COVID-19 Infection Among the General Community, Frontline Workers, and Healthcare Workers During the Second and Third Wave in North India: A Longitudinal Study

Chaudhary, A., Bansal, P., Satija, M., Singh, S. P., Gupta, V. K., Sharma, P., Sharma, S., & Girdhar, S. (2024) · Cureus · doi:10.7759/cureus.58860 · Cited by 1

COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine

Morlacchi, L. C., Alicandro, G., Renteria, S. U., Zignani, N., Giacomel, G., Rossetti, V., Sagasta, M., Citterio, G., Lombardi, A., Dibenedetto, C., et al. (2024) · Transplant International · doi:10.3389/ti.2024.12729 · Cited by 1

A case-control study of behavioural and built environment determinants of COVID-19 transmission in sheltered markets

Li, J., Yang, J., Unni, B., Yap, R., Lim, J. T., Nazeem, M., Shen, J., Teoh, Y. L., Ng, L. C., & Sim, S. (2024) · Building and Environment · doi:10.1016/j.buildenv.2024.111909 · Cited by 1

Cycle threshold values and SARS-CoV-2 variant associations with breakthrough infections: a retrospective study in Accra, Ghana

Aboagye, F. T., Annison, L., Aidoo, E. K., Acquah, M. E., Ashong, Y. A., Oppong, B. B., Osae-Nyarko, L., Owusu-Frimpong, I., Hackman, H. K., Annison, S., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11732-6 · Cited by 1

SARS-CoV-2 Variants: Surveillance, Evaluation, and Challenges

Huang, B., & Tan, W. (2021) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000019 · Cited by 1

Accounting for Pandemic: Better Numbers for Management and Policy

Biondi, Y. (2021) · Accounting Economics and Law - A Convivium · doi:10.1515/ael-2021-0075 · Cited by 1

Clinico-Demographic Profile of Vaccinated/Partially Vaccinated Versus Non-Vaccinated Covid-19 Cases in Second Wave of India

Arora, P., Gupta, N., Rathee, D., & Jimmy, J. K. (2022) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2022/23 · Cited by 1

Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis—A systematic review

Federspiel, J. M., Ramsthaler, F., Kettner, M., & Mall, G. (2022) · Rechtsmedizin · doi:10.1007/s00194-022-00587-9 · Cited by 1

Breath‐holding physiology, radiological severity and adverse outcomes in COVID ‐19 patients: A prospective validation study

Messineo, L., Fanfulla, F., Pedroni, L., Pini, F., Borghesi, A., Golemi, S., Vailati, G., Kerlin, K., Malhotra, A., Corda, L., et al. (2022) · Respirology · doi:10.1111/resp.14336 · Cited by 2

Breakthrough COVID-19 infection according to the infectious diseases hospital

Galiullina, M. S., Халиуллина, С. В., Саубанович, Х. Х., Ринатович, Г. М., Михайловна, М. Т., & Алексеевич, А. В. (2022) · Kazan medical journal · doi:10.17816/kmj2022-541 · Cited by 1

Prognosis of COVID-19 in the middle eastern population, knowns and unknowns

Dandachi, I., & Aljabr, W. A. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.974205 · Cited by 1

Estimate of undetected severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in acute-care hospital settings using an individual-based microsimulation model

Jones, K., Hadley, E., Preiss, S., Lofgren, E., Rice, D. P., Stoner, M. C. D., Rhea, S. K., & Adams, J. W. (2022) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2022.174 · Cited by 1

Adverse effect signature extraction and prediction for drugs treating COVID-19

Wang, H., Wang, X., Teng, L., Lai, D., & Zhang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1019940 · Cited by 1

Breakthrough covid-19 infections among health care workers and their family members in fourth wave of pandemic in myanmar: is third dose enough?

Pyar, K. P. (2022) · Journal of Clinical Research and Reports · doi:10.31579/2690-1919/262 · Cited by 1

Implementation of the COVID 19 Vaccination Program for Children Aged 6-11 Years at Lhokseumawe, Aceh Province, Indonesia

Dewi, R., Maisyura, M., Fitri, D., Malahayati, A., & Sharani, M. (2022) · International Journal of Advances in Social Sciences and Humanities · doi:10.56225/ijassh.v1i4.96 · Cited by 1

COVID-19 MORTALITY CASES IN KUBANG PASU DISTRICT

Itam, M. F., Ibrahim, M. Z., Ismail, K. S. K., Ismail, M. I., & Yusof, M. A. M. (2022) · Malaysian Journal of Public Health Medicine · doi:10.37268/mjphm/vol.22/no.3/art.1675 · Cited by 1

Genomic analysis of SARS-CoV-2 breakthrough infections from Varanasi, IndiaPreprint

Zaveri, L., Singh, R., Basu, P., Banu, S., Mukherjee, P., Vishwakarma, S., Sahni, C., Kaur, M., Singh, N., Yadav, A., et al. (2021) · medRxiv · doi:10.1101/2021.09.19.21262487 · Cited by 1

Efficacy of a polyherbal formulation in the treatment of SARS CoV-2 disease: An open labelled feasibility studyPreprint

Kanchibhotla, D., Harsora, P., Subramanian, S., reddy, R., & Hari Venkatesh, K. R. (2021) · Research Square · doi:10.21203/rs.3.rs-923003/v1 · Cited by 1

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccinationPreprint

Zhou, R., Wang, P., Wong, Y.-C., Xu, H., Lau, S.-Y., Liu, L., Mok, B. W.-Y., Peng, Q., Liu, N., Woo, K. F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.21.465252 · Cited by 1

Effectiveness of Four Vaccines in Preventing SARS-CoV-2 Infection in KazakhstanPreprint

Nabirova, D., Horth, R., Smagul, M., Nukenova, G., Yesmagambetova, A., Singer, D. A., Henderson, A. K., & Tsoy, A. (2022) · medRxiv · doi:10.1101/2022.04.14.22273868 · Cited by 1

Exploring Impacts to COVID-19 Herd Immunity Thresholds Under Demographic Heterogeneity that Lowers Vaccine Effectiveness

Paris, C. F., Spencer, J. A., Castro, L. A., & Valle, S. Y. D. (2022) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/1874147 · Cited by 1

Performance of Rapid Antigen Tests Based on Symptom Onset and Close Contact Exposure: A secondary analysis from the Test Us At Home prospective cohort studyPreprint

Herbert, C., Wang, B., Lin, H., Hafer, N., Pretz, C., Stamegna, P., Tarrant, S., Hartin, P., Ferranto, J., Behar, S., et al. (2023) · medRxiv · doi:10.1101/2023.02.21.23286239 · Cited by 1

A High-Throughput Platform for Rapid Adaptation of DNA Aptamers to SARS-CoV-2 EvolutionPreprint

He, Y., Yang, Z., Kuo, Y.-A., Wu, Y., Fonseca-Albert, D., Le, K. K., Guo, J. G., Wang, Y., Nguyen, A.-T., Chen, Y.-I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.21.719937 · Cited by 1

The association of vaccination and the incidence of new cases of COVID-19 among health care workers, December 16, 2020 through May 4, 2021Preprint

Akhrass, F. A., Reynolds, N., Akhrass, C. A., Dawahare, J. H., Raj, R., Green, G., & Hom, R. C. (2021) · Research Square · doi:10.21203/rs.3.rs-612401/v1

The Great Unmasking of 2021

Gennaro, S. (2021) · Journal of Nursing Scholarship · doi:10.1111/jnu.12688

Using Novel, Agent-Based Periodic Mobility Model with Super Spreaders to Analyze Vaccination Strategies for COVID-19Preprint

Jacob, M., & Guo, E. X. (2021) · medRxiv · doi:10.1101/2021.08.09.21261809

Epidemiological Characteristics of Imported COVID-19 Cases, March to December 2020, Chengdu, China: Implication for Quarantine and Isolation of International TravelersPreprint

Zhang, W., Yue, Y., Min, H., Du, C., Wang, C., Tuo, X., Jiang, X., Fan, S., Chen, Z., Chen, H., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-815516/v1

New-Onset Insulin Allergy After COVID-19 Infection in an Insulin-Dependent Type-2 Diabetic Patient: A Rare Complication

Qureshi, K., Naeem, N., Tariq, J., Chaudhry, M. S., & Pasha, F. (2021) · Cureus · doi:10.7759/cureus.17879

SARS-CoV-2 vaccines breakthrough infection hospitalizations after one dose in Libya: cohort studyPreprint

Abdelhamid, M. H. M., Almsellati, I. A., Annajar, B. B., Abdelhamid, A. H., Alemam, H. A., & Etikar, M. (2021) · medRxiv · doi:10.1101/2021.09.26.21263691

SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care

Siripassorn, K., Huang, A. T., Nitiyanontakij, R., Uttayamakul, S., Klungthong, C., Hunsawong, T., Rungrojcharoenkit, K., Lohachanakul, J., Kodchakorn, C., Vanachayangkul, P., et al. (2021) · International Journal of Coronaviruses · doi:10.14302/issn.2692-1537.ijcv-21-3924

COVID19 - Far from Over: Call for Urgent Novel and Advanced Measures

Mukherjee, S., & Choudhury, A. (2021) · Coronaviruses · doi:10.2174/2666796702666211102111805

[Development of the hormonal reaction to stress in the ontogenesis of the baboon Papio hamadryas].

Butnev, V. I., & Goncharov, N. P. (1987) · PubMed

Zašto neki političari, novinari i zdravstveni djelatnici zagovaraju cijepljenje djece protiv covid-19?Preprint

Gabrić, P. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/sjhra

The Future Disease Burden of Pandemic Covid-19 for Individuals, Communities, and Society

Michaels, R. A. (2021) · Environmental Claims Journal · doi:10.1080/10406026.2021.2015821

Perception Analysis Of Health Workers' Stress During the Covid-19 Pandemic

Hz, H., & Rosalina, S. (2022) · Eduvest - Journal Of Universal Studies · doi:10.36418/edv.v2i2.363

Technical note: The calculated real world BNT162b2 vaccine efficacy was 88% when accounting for asymptomatic cases

Junghans, R. P. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1994800

COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donorsPreprint

Grebe, E., Yu, E. A., Bravo, M. D., Welte, A., Bruhn, R. L., Stone, M., Green, V., Williamson, P. C., Feldstein, L. R., Jones, J. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1551694/v1

Estimating the number of breakthrough COVID-19 deaths in the United StatesPreprint

Smith, J. (2022) · medRxiv · doi:10.1101/2022.04.04.22272731

Hubungan Antara Usia dengan Ada Tidaknya Gejala Sesak Napas pada Pasien COVID-19

Mayorinalia, T. S. D., Stefany, A., Witono, J., Pangestu, P. R. A., & Wulandari, A. S. (2022) · CoMPHI Journal Community Medicine and Public Health of Indonesia Journal · doi:10.37148/comphijournal.v2i2.63

Epidemiological Characteristics of Imported COVID-19 Cases, March to December 2020, Chengdu, China: Implication for Quarantine and Isolation of International TravelersPreprint

Zhang, W., Yue, Y., Min, H., Du, C., Wang, C., Tuo, X., Jiang, X., Fan, S., Chen, Z., Chen, H., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-815516/v2

Rate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS CoV-2 disease: A Single-arm trialPreprint

Kanchibhotla, D., Harsora, P., Subramanian, S., reddy, R., & Hari Venkatesh, K. R. (2021) · Research Square · doi:10.21203/rs.3.rs-923003/v4

COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donorsPreprint

Grebe, E., Yu, E. A., Bravo, M. D., Welte, A., Bruhn, R. L., Stone, M., Green, V., Williamson, P. C., Feldstein, L. R., Jones, J. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1551694/v2

Rate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS CoV-2 disease: A Single-arm trialPreprint

Kanchibhotla, D., Harsora, P., Subramanian, S., reddy, R., & Hari Venkatesh, K. R. (2021) · Research Square · doi:10.21203/rs.3.rs-923003/v3

Breakthrough Infections of COVID-19 among Vaccinated Healthcare Workers in a Tertiary Care Hospital in Northern Kerala, India

Surendranath, S., Kurup, A. S., & Sebastian, C. L. (2022) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.16.2.30

POST VACCINATION COVID POSITIVE INPATIENTS IN A TERTIARY CARE HOSPITAL – AN ANALYSIS

Keerthana., S., Kulandaiammal, M., Jamila, A., & Dharani Sudha, G. (2022) · Indian Journal Of Applied Research · doi:10.36106/ijar/9802083

Letter to editor about the articles of “Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections”

Lin, H.-C., Tseng, C.-F., & Wei, J. C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.05.019

Coronaviruses Research in BRICS Countries

Fielding, B. C., & Schäfer, G. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-4027-6

The Relationship between Understanding of Materials and Burnout with Stress Levels of Nursing Students at Bale Bandung University (UNIBBA) In E-Learning Learning During the Covid-19 Pandemic

Solihat, S., Hasbullah, S. O., & Jahirin, J. (2022) · KESANS International Journal of Health and Science · doi:10.54543/kesans.v1i7.76

Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain

Giesen, C., Saa-Requejo, C. M., López-Carrillo, I., Ortega-Torres, A., & García‐Fernández, C. (2022) · Vacunas · doi:10.1016/j.vacun.2022.05.004

COVID-19 vaccine breakthrough infections among fully vaccinated Health Care Workers in Lagos, NigeriaPreprint

Oladele, D. A., Salako, A. O., James, A. B., Onwuamah, C. K., Usman, O., Abubakar, R., Liboro, G., Odubela, O., Mogaji, S., Ige, F. A., et al. (2022) · medRxiv · doi:10.1101/2022.06.22.22276765

Recurrent COVID-19 suggesting reinfection among seven health care workers in a teaching hospital in Mumbai

Shah, A. K., Raul, M. U., Anto, R. M., & Dakshit, K. (2022) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20221800

COVID-19 Vaccine Breakthrough Infections and Associated Factors in Kwekwe City, Zimbabwe, 2021

Makova, N. C., Muchekeza, M., Chadambuka, A., Govha, E., Juru, T., Gombe, N. T., & Tshimanga, M. (2022) · Open Journal of Epidemiology · doi:10.4236/ojepi.2022.122015

Infección por SARS-CoV-2 posterior a la inmunización artificial e híbrida en el personal de salud

López-Contreras, J. E., Castillo-Vélez, F. E., Gutierrez, G. M., Marrón, J. S., Martínez, E. P. S., & Paredes-Casillas, P. (2022) · ALERTA Revista Científica del Instituto Nacional de Salud · doi:10.5377/alerta.v5i2.14395

Analysis of Factors Influencing COVID-19 Mortality among Vaccinated People in Peru

(2022) · International Workshop on Computer Science and Engineering (WCSE) · doi:10.18178/wcse.2022.06.026

US COVID-19 State Mortality and Case Progression – A Second Midterm Report Card (Delta Surge)

Lin, V. W.-H., Lin, D., & Zhang, X. (2021) · Science Journal of Clinical Medicine · doi:10.11648/j.sjcm.20211004.23

Comparison of Disease Severity and In-hospital Outcome of COVID-19 among Non-vaccinated versus Vaccinated (1st dose) Hospitalized Patients in a Tertiary Care Hospital: an Observational Study

Rishad, M. M., Reza, I. B., Noor, N., Chowdhury, T., Hossain, H. T., Zahiruddin, M., Islam, Q. T., Ahasan, H. N., & Azad, K. A. K. (2022) · Bangladesh Journal of Medicine · doi:10.3329/bjm.v33i3.61376

Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January–March 2021

Sadigh, K. S., Kugeler, K. J., Bressler, S. S., Massay, S., Schmoll, E., Milroy, L., Cavanaugh, A. M., Sierocki, A., COVID-19 Vaccine Breakthrough Characterization Team, Dorough, L., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07702-x · Cited by 1

Assessment of SARS-CoV-2 vaccination status in SARS-COV-2 infected patients admitted in Dr Ruth K.M. Pfau, Civil Hospital Karachi

Rasheed, T., Ali, F. S., Zuberi, B. F., & Sadaf, R. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.8.5733

Autoimmune Hemolytic Anemia After Inactivated Virus COVID-19 Vaccination: A Report of 2 Cases

Insiripong, S., Anantasetagoon, T., & Sanglutong, L. (2022) · Ramathibodi Medical Journal · doi:10.33165/rmj.2022.45.3.256357

Clinical profile of ChAdOx1 nCoV-19- and BBV152-vaccinated individuals among hospitalized COVID-19 patients: a pair-matched study

Keri, V. C., Arunan, B., Kodan, P., Soneja, M., Nischal, N., Varadarajan, A., Didwania, A., Brunda, R. L., Aggarwal, A., Jorwal, P., et al. (2022) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355221115009

Likelihood of COVID-19 reinfection in an urban community cohort in Massachusetts

Casey, S. M., Legler, A., Hanchate, A. D., & Perkins, R. B. (2022) · Dialogues in Health · doi:10.1016/j.dialog.2022.100057 · Cited by 1

COVID-19 Infection After Vaccination Among Healthcare Workers at a Tertiary Level Health Care Center in Northern India: A Cross-Sectional Study

Sharma, N., Singh, M., Aggarwal, P., Bahurupi, Y. A., Panda, P. K., & Saxena, G. (2022) · Recent Advances in Anti-Infective Drug Discovery · doi:10.2174/2772434417666221011095128

Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience

Strickler, S. S., Esper, A. M., Wells, L., Wood, A. R., Frediani, J. K., Nehl, E. J., Waggoner, J. J., Rebolledo, P. A., Levy, J. M., Figueroa, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1031083

Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021

Nickel, K. B., Fraser, V. J., Babcock, H. M., & Kwon, J. H. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.299

Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain

Giesen, C., Saa-Requejo, C. M., López-Carrillo, I., Ortega-Torres, A., & García‐Fernández, C. (2022) · Vacunas (English Edition) · doi:10.1016/j.vacune.2022.10.013 · Cited by 1

Does COVID-19 Vaccine Impact the Soul? A Pre-post Vaccination Comparison of Health Care Workers’ Infection Control Practices and Perspectives

Khalid, I., AKHTAR, M. A., Imran, M., Imran, M., Mujalli, M. A., Qashqari, M. S., Alshukairi, A. N., Nisar, A., & Khalid, T. J. (2022) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001177

A Study on The Efficacy of Vaccination in Elderly Patients with Breakthrough COVID-19 Infection

Choi, S., Choi, Z., Ha, C., Lee, H.-J., & Kim, C. M. (2022) · 대한임상노인의학회지 · doi:10.15656/kjcg.2022.23.2.115

Scales, Pseudoscales, the Human Factor, and a Way Forward

Mueller, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-18903-6_7

COVID-19 Breakthrough Infections among Medical Students under the SLICE and CLARO Programs: Ateneo School of Medicine and Public Health Experience

Carlos-Dollaga, P. D. L., Dy, A. B. C., & Cabigon, J. J. J. (2023) · Acta Medica Philippina · doi:10.47895/amp.vi0.6523

The association of demographic and socioeconomic factors with COVID-19 during pre- and post-vaccination periods: A cross-sectional study of Virginia

Tan, W. (2023) · Medicine · doi:10.1097/md.0000000000032607

SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 – June 30, 2021

Darby, B. J., Alexander, V., & Murphy, J. M. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.01.041

Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases

Emami, A., Javanmardi, F., Bakhtiari, H., Rezaei, T., Hemmati, A., Akbari, A., & Pirbonyeh, N. (2023) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2023.4

Coronavirus disease 2019 vaccine in pediatric post‐kidney transplantation

Ajlan, A. A., Aleid, H. A., Ali, T. Z., Devol, E. B., Marquez, K. A. H., AlDhaferi, R. F., Karar, E., Mohammed, A. E. I., Tiba, M., Fajji, L., et al. (2023) · Clinical Transplantation · doi:10.1111/ctr.14983 · Cited by 1

Role of vaccination and anti-SARS-CoV-2 antibodies in the clinical outcome of hospitalized COVID-19 patients

Bernal, E., García-Villalba, E., Pons, E., Vicente, M. R., Tomás, C., Minguela, A., Hernández, M. D., Puche, G., Carter, P., Martínez, M. M., et al. (2023) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.12.015

Comparison of Severity of COVID-19 Infections between Vaccinated and Unvaccinated Patients with Comorbidities in the Third Wave

(2023) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v11i5.05

Navigating the COVID-19 Pandemic: Examining Changes in Global Incidence and Mortality with Emphasis on Vaccine Coverage Base on the Omicron Era

Park, M.-B. (2023) · Asia-pacific Journal of Convergent Research Interchange · doi:10.47116/apjcri.2023.07.23

Dosis diarias de vacuna COVID-19 administradas en el mundo

Pinzón, J. E. D. (2023) · Revista de Investigaciones Universidad del Quindío · doi:10.33975/riuq.vol35n2.818

Severity of SARS-CoV-2 infection among vaccinated individuals: A hospital-based study

Govindapala, D., Jayasekara, P., Rajramanan, R., & de Silva, N. L. (2022) · Ceylon Medical Journal · doi:10.4038/cmj.v67i4.9742

The Pattern of COVID-19-related Pneumonitis on High-Resolution Computed Tomography Chest in Post-Vaccination Patients

Ullah, H., Saleem, H., Mahmood, R., Afzal, T., Saleem, R., & Mahmood, A. (2023) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v73i4.8462

Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate

Hsu, C., Yang, W.-W., Hou, C.-Y., Feng, I., Huang, T., Lee, P., Guo, H., Huang, C.-Y., & Su, S. (2023) · Life · doi:10.3390/life13122326

Sağlık Personelinin Covıd-19 Aşısı Hakkında Bilgi Farkındalığı ve Tereddütleri

Karabulutlu, Ö., & KAVAS, T. (2023) · Caucasian Journal of Science · doi:10.48138/cjo.1381409

COVID-19 and Surgery: Getting Back to Business

Myles, P. S. (2024) · Anesthesiology · doi:10.1097/aln.0000000000004826

Incidence of breakthrough infection after COVID vaccination and effect of post-covid-19 syndrome on medical students in a tertiary care hospital in Telangana

Khan, M. F., Bompalli, S. A., Roopa, C., & Shilpa, P. N. (2024) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2023.049

Molecular, Immunological, and Clinical Characterization of SARS-CoV-2 Infection in Breakthrough-Infected Healthcare Workers During the Last Wave of The Pandemic in Shiraz, Iran

Saeb, S., Talei, G. R., Ghaziasadi, A., Letafati, A., Khanizadeh, S., & Jamalidoust, M. (2024) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-142644

Relationship between COVID-19 Vaccination Status and Comorbidities of COVID-19 Patients Admitted at a Tertiary Medical College in Calicut District, Kerala

Dabas, P., Harsha, P., Henry, S., & Binub, K. (2023) · Dentistry and Medical Research · doi:10.4103/dmr.dmr_45_23

Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in Malaysia

Tamim, H., Hashim, R., Jamil, N., Chong, L. Y., & Johari, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29574

Severity of respiratory illness among Covid-19-vaccinated and non-vaccinated admitted patients—An observational study from a teaching hospital of Tripura

Majumder, V., Choudhury, C., Goswami, B., Sengupta, S., & Bhattacharjee, B. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1643_23

Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4–11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter study

Eviatar, T., Ziv, A., Oved, A., Miller‐Barmak, A., Pappo, A., Livny, R., Amarilyo, G., Aviel, Y. B., Naor, R., Pel, S., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126426

Factors influencing COVID-19 vaccine breakthrough infections: an analysis of healthcare workers in Ardabil, Iran

Rezaei, E., Aliasgarzadeh, S., Mirak, S. M., & Tayyar-Iravanlou, F. (2024) · Health Science Monitor · doi:10.61186/hsm.3.4.306

Side Effect: Myocarditis as a Potential Side Effect of mRNA Vaccines

Becktel, K. (2024) · Risk, systems and decisions · doi:10.1007/978-3-031-74062-6_17

Impact of SARS-CoV-2 inactivated vaccine on symptoms following omicron variant breakthrough infection

Zhang, Y., Li, X., Yang, Y., Yin, Y., Zhong, Y., Xu, Q., Tu, J., Deng, J., Liang, H., & Shen, T. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126722

Application and significance of SIRVB model in analyzing COVID-19 dynamics

Ariyaratne, P., Ramasinghe, L. P., Ayyash, J. S., Kelley, T. M., Plant-Collins, T. A., Shinkle, L. W., Zuercher, A., & Chen, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-90260-4

Interplay Between Viral Shedding, Age, and Symptoms in Individual Infectivity of COVID-19 Breakthrough Infections in Households

Dong, S., Sun, Y., Ni, S., Tian, Y., Feng, Z., Jia, L., Wang, X., Zhang, D., Wang, Q., Tsang, T. K., et al. (2025) · Vaccines · doi:10.3390/vaccines13030329

Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021

Kugeler, K. J., Williamson, J., Curns, A. T., Healy, J. M., Nolen, L. D., Clark, T. A., Martin, S. W., & Fischer, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264179

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19

Parums, D. V. (2021) · Medical Science Monitor · doi:10.12659/msm.935624 · Cited by 4

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness

Reynolds, M. W., Xie, Y., Knuth, K. B., Mack, C. D., Brinkley, E., Toovey, S., & Dreyer, N. A. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1

The impact of vaccination on COVID-19

Shamama, F., Zhamutashvili, M., Dolmazashvili, E., Badridze, N., Gognadze, T., & Sharvadze, L. (2023) · Journal of Biomedical and Medical Sciences · doi:10.51231/2667-9507-2023-002-01-62-66 · Cited by 1

POSC419 Examining the Rate of COVID-19 Breakthrough Infections in Individuals Who Received mRNA Vaccine in the United States

Madge, V. J., Bhardwaj, N., & Mazumder, D. (2022) · Value in Health · doi:10.1016/j.jval.2021.11.1320